SLPI and ovarian carcinoma: WFDC4, predominantly studied in ovarian cancer, affects tumor invasion and metastasis by regulating the PI3K-AKT signaling pathway and MMP-9 secretion (Sun et al., 2022; Hoskins et al., 2011).